Filing Flows › Kestra Medical Technologies (KMTS) › Q4 FY26 › vs Q4 FY25
Kestra Medical Technologies (KMTS) Q4 FY26 vs Q4 FY25 (year over year)
Kestra Medical Technologies's revenue rose $11.4M (+66%) from $17.2M in Q4 FY25 to $28.6M in Q4 FY26.
Kestra Medical Technologies, Q4 FY26: revenue $28.6M (+66% year over year), operating margin -137.4%, net loss $38.8M, operating cash flow −$18.7M. The chart draws each line against Q4 FY25, the increases inside each band.
Every line
| Line | Q4 FY26 | Q4 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $28.6M | $17.2M | $11.4M | +66% |
| Other income, net | $701K | −$2.8M | $3.5M | — |
| Net loss | $38.8M | $51.1M | −$12.3M | -24% |
| Costs & expenses | $68.2M | $68.3M | −$170K | -0.2% |
| Operating costs | $68.0M | $65.4M | $2.5M | +4% |
| Income tax | $192K | $102K | $90K | +88% |
| Cost of revenue | $13.0M | $9.6M | $3.4M | +35% |
| Research & development | $5.6M | $5.4M | $248K | +5% |
| SG&A | $49.4M | $50.5M | −$1.1M | -2% |
| Operating cash sources | $38.8M | $51.1M | −$12.3M | -24% |
| Depreciation | $2.3M | $1.8M | $489K | +27% |
| Share-based compensation | $10.3M | $22.3M | −$12.0M | -54% |
| Working capital & other | $7.5M | $2.9M | $4.6M | +158% |
| Cash used in operations | $18.7M | $24.1M | −$5.3M | -22% |
| Net loss absorbed | $38.8M | $51.1M | −$12.3M | -24% |
Questions
How much did Kestra Medical Technologies's revenue grow year over year in Q4 FY26?
Kestra Medical Technologies's revenue rose $11.4M (+66%) from $17.2M in Q4 FY25 to $28.6M in Q4 FY26.